Steve Pakola sold $689K of REGENXBIO (RGNX)

Executed Jun 29, disclosed Jul 2, 2 days later.

Value, as filed

$689K

56,333 sh across 2 lots

Executed

Jun 29

the trade date, as filed

Disclosed

Jul 2

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Steve Pakola Chief Medical Officer profile →

Steve Pakola (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in REGENXBIO Inc. (RGNX). The largest single filing was $689K of RGNX (56,333 sh across 2 lots, as filed), executed Jun 29.

The name

RGNX

REGENXBIO Inc. RGNX · Healthcare · 6 filings in 24 months ticker →

Healthcare · REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Steve Pakola in RGNX

RGNXSALE REGENXBIO Inc. $169K
15,309 sh × $11.02
Exec May 11
Filed May 13 · 5:30 PM ET